Lifecore Biomedical, Inc. (LFCR)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.11
+0.37%
Mkt Cap $261.51M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.50
Range $6.50 – $6.50
Implied Upside
+58.3%
Consensus $6.50 vs current $4.11